Serial #88125992
LIVE

Serial Number

88125992

Owner

SUZHOU KINTOR PHARMACEUTICALS, INC.

Attorney

Alex Patel

Filing Date

Sep 20, 2018

Add to watchlist:

No watchlists yet
View on USPTO

Serial #88125992 Trademark

Serial Number: 88125992 • Registration: 6127305

Serial #88125992 is a trademark filed by SUZHOU KINTOR PHARMACEUTICALS, INC. on September 20, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

SUZHOU KINTOR PHARMACEUTICALS, INC. (6 trademarks)

NO.20, SONGBEI ROAD, SUZHOU INDUSTRIAL PARK
SUZHOU CITY, JIANGSU PROVINCE 215123 , CN

Entity Type: 99

Kintor Pharmaceutical Limited (3 trademarks)

P.O. Box 2075, #31 The Strand
Grand Cayman , KY

Entity Type: 99

Trademark Details

Filing Date

September 20, 2018

Registration Date

August 18, 2020

Published for Opposition

December 31, 2019

Goods & Services

Medicines for treatment of cancer; sachets for pharmaceutical purposes, medicines in the form of capsules, chemico-pharmaceutical preparations, drugs for medical purposes, chemical preparations for pharmaceutical purposes, biological preparations for medical purposes, chemical preparations for medical purposes, all of the foregoing for the treatment of cancer; anti-cancer pharmaceutical preparations; pharmaceutical preparations for the diagnosis and treatment of cancer; pharmaceutical products for the prevention, diagnosis, treatment and adjunctive therapy of cancer, cardiovascular disease, nervous system diseases, infectious diseases, respiratory diseases, endocrine and metabolic diseases, mental disorder, skin disease, diseases of the blood system, digestive system diseases, immune system diseases, diseases of genitourinary system, ocular diseases, otolaryngology and dentistry diseases, musculoskeletal and connective tissue diseases, nutritional diseases, diseases caused by external factors, namely, poisoning and injury; compounds for treating cancer; pharmaceuticals, medical and veterinary preparations for the prevention, diagnosis, treatment and adjunctive therapy of cancer, cardiovascular disease, nervous system diseases, infectious diseases, respiratory diseases, endocrine and metabolic diseases, mental disorder, skin disease, diseases of the blood system, digestive system diseases, immune system diseases, diseases of genitourinary system, ocular diseases, otolaryngology and dentistry diseases, musculoskeletal and connective tissue diseases, nutritional diseases, diseases caused by external factors, namely, poisoning and injury; sanitary preparations for medical purposes; dietetic food and substances, namely, dietetic foods, sugar substitutes, nutritional beverages, and dietary supplements for weight loss adapted for medical and veterinary use; food for babies; dietary supplements for humans and animals; plasters and materials, namely, gauze for medical dressings; materials for dental fillings and for sealing purposes; dental wax; disinfectants; preparations for destroying vermin; fungicides; herbicides

Retail pharmacy services; advertising services; business management; business administration services; providing office functions; information, advisory and consultancy services relating to all the aforesaid services

Pharmaceutical compounding services; providing medical information and information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical advice in the field of medicine, pharmacology, medical analysis and diagnostics; provision of medical services in the field of alternative medicine; providing medical information relating to medicine, pharmacology and medical diagnosis; medicine and treatment prescription services, namely, services relating to the diagnosis of illness and prescription of medicine; medicine and treatment prescription services, namely, home health care services, managed health care services; physical therapy services; medical diagnostic testing, monitoring and reporting services; medical services; veterinary services; hygienic and beauty salon and consultation services for human beings and animals; medicine and treatment prescription services, namely, insecticide spraying, vermin extermination for agriculture, horticulture and forestry; information, advisory and consultancy services relating to all the aforesaid services

Scientific and medical research services; pharmaceutical research services; research relating to pharmaceuticals; research and development of pharmaceutical products; biotechnology research; biochemistry and chemical research services; scientific research relating to biology and chemistry; scientific research in the field of pharmacy; scientific research into the development of new products; testing services for assessing the efficacy and safety of pharmaceuticals; preparation of reports relating to scientific research; analytical medical and scientific laboratory services; medical and scientific laboratory research and analysis; development of products; development of pharmaceutical preparations for the diagnosis and treatment of cancer; advisory services relating to scientific research; scientific and technological services in the field of pharmaceuticals and research and design relating thereto, namely, consulting and advisory services, CRO (Contract Research Organization) and CDMO (Contract Development and Manufacturing Organization) services; industrial analysis and research services in the field of pharmaceuticals; design and development of computer hardware and software; information, advisory and consultancy services relating to all the aforesaid services

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 18, 2025 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 7, 2025 ASGN
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Apr 23, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 23, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 23, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 23, 2025 REAP
CORRECTION UNDER SECTION 7 - PROCESSED
Mar 9, 2021 COC.
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Mar 8, 2021 EROP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 4, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 4, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 4, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 4, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 4, 2021 COAR
POST REGISTRATION ACTION MAILED - SEC. 7
Dec 9, 2020 PRAM
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 9, 2020 APRE
TEAS SECTION 7 REQUEST RECEIVED
Sep 15, 2020 ES7R
REGISTERED-PRINCIPAL REGISTER
Aug 18, 2020 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Jul 16, 2020 DP1B
NOTICE OF ALLOWANCE CANCELLED
Jul 9, 2020 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Jul 9, 2020 D1BR
NOTICE OF ALLOWANCE CORRECTION ENTERED
Apr 30, 2020 ICNA
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 30, 2020 AITU
TEAS POST PUBLICATION AMENDMENT RECEIVED
Apr 3, 2020 EPPA
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 25, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 31, 2019 NPUB
PUBLISHED FOR OPPOSITION
Dec 31, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 11, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 22, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 22, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 22, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 22, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 22, 2019 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Nov 22, 2019 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Nov 5, 2019 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 21, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 15, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 15, 2019 CRFA
ASSIGNED TO LIE
Oct 14, 2019 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Oct 9, 2019 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 13, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 13, 2019 GNSL
SUSPENSION LETTER WRITTEN
Jul 13, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 9, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 8, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 8, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 7, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jan 7, 2019 GNRT
NON-FINAL ACTION WRITTEN
Jan 7, 2019 CNRT
ASSIGNED TO EXAMINER
Jan 2, 2019 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 28, 2018 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 27, 2018 NWOS
NEW APPLICATION ENTERED
Sep 24, 2018 NWAP